TY - JOUR TI - Harnessing the power of human tumor-derived cell lines for the rational design of cancer therapies. AU - Plaisier, Christopher L. AU - Baliga, Nitin S. T2 - Pigment cell & melanoma research DA - 2012/07//undefined PY - 2012 DO - 10.1111/j.1755-148X.2012.01020.x VL - 25 IS - 4 SP - 406 EP - 408 J2 - Pigment Cell Melanoma Res LA - eng SN - 1755-148X 1755-1471 KW - *Drug Design KW - Antineoplastic Agents/pharmacology/therapeutic use KW - Cell Line, Tumor KW - Drug Resistance, Neoplasm/drug effects KW - Drug Screening Assays, Antitumor/*methods KW - Drug Therapy, Combination KW - Genetic Variation KW - Humans KW - Neoplasms/*drug therapy/genetics/*pathology ER -